BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15378566)

  • 1. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
    Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
    J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
    Wong NA; Britton MP; Choi GS; Stanton TK; Bicknell DC; Wilding JL; Bodmer WF
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):574-9. PubMed ID: 14704280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
    Ku JL; Kang SB; Shin YK; Kang HC; Hong SH; Kim IJ; Shin JH; Han IO; Park JG
    Oncogene; 2004 Sep; 23(40):6736-42. PubMed ID: 15273736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
    Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
    J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells.
    Schneider-Stock R; Kuester D; Ullrich O; Mittag F; Habold C; Boltze C; Peters B; Krueger S; Hintze C; Meyer F; Hartig R; Roessner A
    J Pathol; 2006 May; 209(1):95-105. PubMed ID: 16575786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
    Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
    Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
    Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
    Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma.
    Butler LM; Dobrovic A; Bianco T; Cowled PA
    Br J Cancer; 2000 Jan; 82(1):131-5. PubMed ID: 10638979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
    Esteller M; Sparks A; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Gonzalez S; Tarafa G; Sidransky D; Meltzer SJ; Baylin SB; Herman JG
    Cancer Res; 2000 Aug; 60(16):4366-71. PubMed ID: 10969779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent down-regulation of HIVEP2 in human breast cancer.
    Fujii H; Gabrielson E; Takagaki T; Ohtsuji M; Ohtsuji N; Hino O
    Breast Cancer Res Treat; 2005 May; 91(2):103-12. PubMed ID: 15868437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
    Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
    J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis].
    Zhang YY; Chen SQ; Zhu M; Li JT; Ma GJ; Zhang XM; Zhou JN
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):378-81. PubMed ID: 18683131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.